Table 4.
Study | Year | Design | Artroscopic technique |
Total number open/arthroscopic |
Follow-up open/arthroscopic |
Recurrence open/arthroscopic |
---|---|---|---|---|---|---|
Steinbeck et al. | 1998 [40] |
prospective | transglenoid suture | 32/30 | 40/36 months | 6%/17% |
Sisto et al. | 1998 [37] |
retrospective | Suretac | 7/23 | 47/47 months | 0%/13% |
Kartus et al. | 1998 [21] |
retrospective | Suretac | 18/18 | 31/28 months | 0%/0% |
Jorgensen et al. | 1999 [17] |
prospective | transglenoid suture | 20/21 | 36/36 months | 0%/5% |
Kim et al. | 2002 [22] |
retrospective | suture anchors | 30/59 | 39/39 months | 6.7%/3.4% |
Fabbriciani et al. | 2004 [9] |
prospective randomized | suture anchors | 30/30 | 24/24 months | 0%/0% |
Tjoumakaris et al. | 2006 [42] |
retrospective | suture anchors | 24/69 | 42/42 months | 4%/1% |
Bottoni et al. | 2006 [4] |
prospective randomized |
suture anchors | 29/32 | 32/32 months | 7%/3% |
Including subluxations |
||||||
Jorgensen et al. | 1998 [17] |
prospective | transglenoid suture | 20/21 | 36/36 months | 10%/10% |
Cole et al. | 2000 [6] |
prospective | Suretac | 20/37 | 54/54 months | 9%/16% 18%/24% (incl. positive apprehension test) |
Sperber et al. | 2001 [38] |
prospective randomized |
Suretac | 26/30 | 24/24 months | 12%/23% |
Karlsson et al. | 2001 [20] |
prospective | Suretac | 40/60 | 36/28 months | 10%/15% |